Pietro Iaffaldano
Pietro Iaffaldano
Bestätigte E-Mail-Adresse bei uniba.it - Startseite
Zitiert von
Zitiert von
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
Geographical variations in sex ratio trends over time in multiple sclerosis
M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ...
PLOS one 7 (10), e48078, 2012
Treatment decisions in multiple sclerosis—insights from real-world observational studies
M Trojano, M Tintore, X Montalban, J Hillert, T Kalincik, P Iaffaldano, ...
Nature Reviews Neurology 13 (2), 105-118, 2017
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ...
Multiple Sclerosis Journal 20 (6), 739-746, 2014
Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis
VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ...
Annals of neurology 80 (1), 89-100, 2016
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ...
Annals of neurology 89 (4), 780-789, 2021
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial
MP Amato, B Goretti, RG Viterbo, E Portaccio, C Niccolai, B Hakiki, ...
Multiple Sclerosis Journal 20 (1), 91-98, 2014
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study
P Iaffaldano, RG Viterbo, D Paolicelli, G Lucchese, E Portaccio, B Goretti, ...
PloS one 7 (4), e35843, 2012
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis
P Iaffaldano, G Lucisano, C Pozzilli, V Brescia Morra, A Ghezzi, ...
Brain 138 (11), 3275-3286, 2015
Anxiety state affects information processing speed in patients with multiple sclerosis
B Goretti, RG Viterbo, E Portaccio, C Niccolai, B Hakiki, E Piscolla, ...
Neurological Sciences 35 (4), 559-563, 2014
The impact of neutralizing antibodies on the risk of disease worsening in interferon β–treated relapsing multiple sclerosis: a 5 year post-marketing study
D Paolicelli, M D’Onghia, F Pellegrini, V Direnzo, P Iaffaldano, V Lavolpe, ...
Journal of neurology 260 (6), 1562-1568, 2013
Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender
S Zoccolella, C Tortorella, P Iaffaldano, V Direnzo, M D’Onghia, ...
Journal of neurology 259 (10), 2105-2110, 2012
Multiple sclerosis registries in Europe–An updated mapping survey
A Glaser, A Stahmann, T Meissner, P Flachenecker, D Horáková, ...
Multiple sclerosis and related disorders 27, 171-178, 2019
Natural history of multiple sclerosis: have available therapies impacted long-term prognosis?
M Trojano, D Paolicelli, C Tortorella, P Iaffaldano, G Lucchese, ...
Neurologic clinics 29 (2), 309-321, 2011
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
L Prosperini, RP Kinkel, AA Miravalle, P Iaffaldano, S Fantaccini
Therapeutic advances in neurological disorders 12, 1756286419837809, 2019
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
P Iaffaldano, M Ruggieri, RG Viterbo, M Mastrapasqua, M Trojano
Brain, behavior, and immunity 35, 176-181, 2014
Prognostic indicators in pediatric clinically isolated syndrome
P Iaffaldano, M Simone, G Lucisano, A Ghezzi, G Coniglio, ...
Annals of neurology 81 (5), 729-739, 2017
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
T Kalincik, T Spelman, M Trojano, P Duquette, G Izquierdo, P Grammond, ...
PloS one 8 (5), e63480, 2013
Low serum urate levels are associated to female gender in multiple sclerosis patients
S Zoccolella, C Tortorella, P Iaffaldano, V Direnzo, M D’Onghia, ...
Public Library of Science 7 (7), e40608, 2012
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment
M Trojano, F Pellegrini, D Paolicelli, A Fuiani, GB Zimatore, C Tortorella, ...
Journal of the neurological sciences 286 (1-2), 109-113, 2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20